Lymphocyte Activation Gene-3 (LAG-3) negatively regulates environmentally-induced autoimmunity

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Jha, Vibha ^a   Workman, Creg J ^b   McGaha, Tracy L ^a   Li, Liping ^a   Vas, Jaya ^a   Vignali, Dario A A ^b   Monestier, Marc ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 6; LYMPHOCYTE ACTIVATION GENE 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MERCURY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; ANTINUCLEAR ANTIBODY; CD223 ANTIGEN; LEUKOCYTE ANTIGEN; POLLUTANT;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MOUSE; NONHUMAN; WILD TYPE; ANIMAL; B LYMPHOCYTE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; OCCUPATIONAL EXPOSURE; POLLUTANT;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; ENVIRONMENTAL POLLUTANTS; IMMUNE TOLERANCE; IMMUNOGLOBULIN E; INTERFERON-GAMMA; INTERLEUKIN-4; INTERLEUKIN-6; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MERCURY; MICE; OCCUPATIONAL EXPOSURE;

EID: 84928584424     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104484     Document Type: Article

References (55)

1. Schiraldi M, Monestier M (2009) How can a chemical element elicit complex immunopathology? Lessons from mercury-induced autoimmunity. Trends Immunol 30: 502-509.
2. Moszczynski P, Slowinski S, Rutkowski J, Bem S, Jakus-Stoga D (1995) Lymphocytes, T and NK cells, in men occupationally exposed to mercury vapours. Int J Occupational Med Environ Health 8: 49-56.
3. Lauwerys R, Bernard A, Roels H, Buchet JP, Gennart JP, et al. (1983) Antilaminin antibodies in workers exposed to mercury vapour. Toxicol Letters 17: 113-116. (Pubitemid 13054063)
4. Arnett FC, Reveille JD, Goldstein R, Pollard KM, et al. (1996) Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. Arthritis Rheum 39: 1151-1160. (Pubitemid 26240228)
5. Silbergeld EK, Silva IA, Nyland JF (2005) Mercury and autoimmunity: implications for occupational and environmental health. Toxicol Appl Pharmacol 207: 282-292.
6. Hanley GA, Schiffenbauer J, Sobel ES (1998) Resistance to HgCl2-induced autoimmunity in haplotype-heterozygous mice is an intrinsic property of B cells. J Immunol 161: 1778-1785. (Pubitemid 28387597)
7. Vas J, Monestier M (2008) Immunology of mercury. Ann N Y Acad Sci 1143: 240-267.
8. Pollard KM, Hultman P, Kono DH (2005) Immunology and genetics of induced systemic autoimmunity. Autoimmun Rev 4: 282-288. (Pubitemid 40884546)
9. Robinson CJ, White HJ, Rose NR (1997) Murine strain differences in response to mercuric chloride: antinucleolar antibodies production does not correlate with renal immune complex deposition. Clin Immunol Immunopathol 83: 127-138. (Pubitemid 27195932)
10. Hultman P, Bell LJ, Enestrom S, Pollard KM (1992) Murine susceptibility to mercury. I. Autoantibody profiles and systemic immune deposits in inbred, congenic, and intra-H-2 recombinant strains. Clin Immunol Immunopathol 65: 98-109.
11. Hanley GA, Schiffenbauer J, Sobel ES (1997) Class II haplotype differentially regulates immune response in HgCl2-treated mice. Clin Immunol Immunopathol 84: 328-337. (Pubitemid 27398033)
12. Vas J, Mattner J, Richardson S, Ndonye R, Monestier M, et al. (2008) Regulatory roles for NKT cell ligands in environmentally induced autoimmunity. J Immunol 181: 6779-6788.
13. Via CS, Nguyen P, Niculescu F, Papadimitriou J, Silbergeld EK, et al. (2003) Low-dose exposure to inorganic mercury accelerates disease and mortality in acquired murine lupus. Environ Health Perspect 111: 1273-1277. (Pubitemid 37021127)
14. Pollard KM, Pearson DL, Hultman P, Deane TN, Kono DH, et al. (2001) Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone bxsb mice. Environ Health Perspect 109: 27-33. (Pubitemid 32118022)
15. Ziemba SE, Menard SL, McCabe MJ Jr, Rosenspire AJ (2009) T-cell receptor signaling is mediated by transient Lck activity, which is inhibited by inorganic mercury. FASEB J 23: 1663-1671.
16. Workman CJ, Dugger KJ, Vignali DAA (2002) Cutting Edge: Molecular analysis of the negative regulatory function of lymphocyte activation gene-3. J Immunol 169: 5392-5395. (Pubitemid 35291633)
17. Huard B, Gaulard P, Faure F, Hercend T, Triebel F (1994) Cellular expression and distribution of the human LAG-3-encoded protein, an MHC-II ligand. Immunogenetics 39: 213-217. (Pubitemid 24014846)
18. Bruniquel D, Borie N, Triebel F (1997) Genomic organisation of human LAG-3/CD4 locus. Immunogenetics 47: 96-98. (Pubitemid 28062040)
19. Baixeras E, Huard B, Miossec C, Jitsukawa S, Piatier-Tonneau D, et al. (1992) Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens. J Exp Med 176: 327-337.
20. Bertrand H, Prigent P, Tournier M, Bruniquel D, Triebel F (1995) CD4/major histocompatibility complex class II interaction analysed with CD4- and lymphocyte activation gene-3 (LAG-3)- Ig fusion proteins. Eur J Immunol 25: 2718-2721.
21. Workman C, Vignali D (2003) The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells. Eur J Immunol 33: 970-979. (Pubitemid 36546685)
22. Miyazaki T, Dierich A, Benoist C, Mathis D (1996) Independent modes of natural killing distinguished in mice lacking Lag3. Science 272: 405-408. (Pubitemid 26138176)
23. Workman CJ, Vignali DAA (2005) Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223). J Immunol 174: 688-695. (Pubitemid 40094261)
24. Huang CT, Workman J, Flies D, Pan X, Vignali DAA, et al. (2004) Role of LAG-3 in regulatory T cells. Immunity 21: 503-513. (Pubitemid 39370506)
25. Liang B, Workman C, Lee J, Chew C, Clynes R, et al. (2008) Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J Immunol 180: 5916-5926.
26. Triebel F, Jitsukawa S, Baixeras E, Roman-Roman S, Hercend T, et al. (1990) LAG-3, a novel lymphocyte activation gene closely related to CD4. J Exp Med 171: 1393-1405. (Pubitemid 20167538)
27. Abedi-Valugerdi M, Hansson M, Moller G (2001) Genetic control of resistance to mercury-induced immune/autoimmune activation. Scand J Immunol 54: 190-197. (Pubitemid 32592345)
28. Workman CJ, Rice DS, Dugger KJ, Kruschner C, Vignali DAA (2002) Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3). Eur J Immunol 32: 2255-2263. (Pubitemid 34965888)
29. Bagenstose LM, Salgame P, Monestier M (1998) IL-12 down-regulates autoantibody production in mercury-induced autoimmunity. J Immunol 160: 1612-1617. (Pubitemid 28106445)
30. Monestier M, Losman MJ, Novick KE, Aris JP (1994) Molecular analysis of mercury-induced antinucleolar antibodies in H-2S mice. J Immunol 152: 667-675.
31. Li N,Workman CJ, Martin SM, Vignali DAA (2004) Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223). J Immunol 173: 6806-6812. (Pubitemid 39541066)
32. McGaha TL, Karlsson MCI, Ravetch JV (2008) Fc{gamma}RIIB Deficiency Leads to Autoimmunity and a Defective Response to Apoptosis in Mrl-MpJ Mice. J Immunol 180: 5670-5679.
33. Pollard KM, Landberg GP (2001) The in vitro proliferation of murine lymphocytes to mercuric chloride is restricted to mature T cells and is interleukin 1 dependent. Int Immunopharmacol 1: 581-593. (Pubitemid 32197555)
34. Johansson U, Sander B, Hultman P (1997) Effects of the murine genotype on T cell activation and cytokine production in murine mercury-induced autoimmunity. J Autoimmun 10: 347-355. (Pubitemid 27366140)
35. Li N, Wang Y, Forbes K, Vignali KM, Vignali DAA, et al. (2007) Metalloproteases regulate T-cell proliferation and effector function via LAG-3. EMBO J 26: 494-504. (Pubitemid 46160949)
36. Shin H, Wherry EJ (2007) CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol 19: 408-415. (Pubitemid 47284857)
37. Richter K, Agnellini P, Oxenius A (2010) On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection. Int Immunol 22: 13-23.
38. Blackburn SD, Shin H, Haining WN, Zou T, Wherry EJ, et al. (2009) Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 10: 29-37.
39. Grosso JF, Kelleher CC, Harris TJ, Maris CH, Drake G, et al. (2007) LAG-3 regulates CD8+ T cell accumalation and effector function in murine self and tumor-tolerance systems. J Clin Invest 117: 3383-3392. (Pubitemid 350096994)
40. Zarek PE, Huang CT, Lutz ER, Kowalski J, Powell JD, et al. (2008) A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111: 251-259.
41. Kono DH, Balomenos D, Pearson DL, Park MS, Pollard KM, et al. (1998) The prototypic Th2 autoimmunity induced by mercury is dependent on IFN-gamma and not Th1/Th2 imbalance. J Immunol 161: 234-240. (Pubitemid 28285528)
42. Bagenstose LM, Salgame P, Monestier M (1998) Mercury-induced autoimmunity in the absence of interleukin-4. Clin Exp Immunol 114: 9-12.
43. Haggqvist B, Hultman P (2003) Effects of deviating the Th2-response in murine mercury-induced autoimmunity towards a Th1-response. Clin Exp Immunol 134: 202-209. (Pubitemid 37372270)
44. Ochel M, Vohr HW, Pfeiffer C, Gleichmann E (1991) IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol 146: 3006-3011.
45. Pollard KM, Hultman P, Kono DH (2003) Using single-gene deletions to identify checkpoints in the progression of systemic autoimmunity. Ann N Y Acad Sci 987: 236-239. (Pubitemid 36584027)
46. Havarinasab S, Pollard KM, Hultman P (2009) Gold- and silver-induced murine autoimmunity-requirement for cytokines and CD28 in murine heavy metal-induced autoimmunity. Clin Exp Immunol 155: 567-576.
47. Zhu X, Yang P, Zhou H, Li B, Kijlstra A, et al. (2006) CD4+CD25+ Tregs express an increased LAG-3 and CTLA-4 in anterior chamber-associated immune deviation. Graefe's Arch Clin Exp Opthalmol 245: 1549-1557.
48. Fallarino F, Grohmann U, Hwang KW, Orabona, Puccetti P, et al. (2003) Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 4: 1206-1212. (Pubitemid 37547898)
49. Serra P, Amrani A, Yamanouchi J, Han B, Santamaria P, et al. (2003) CD40 ligation releases dendritic cells from the control of CD4+CD25+ regulatory T cells. Immunity 19: 877-889. (Pubitemid 37542307)
50. Houot R, Perrot I, Garcia E, Durand I, Lebecque S (2006) Human CD4+CD25 high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation. J Immunol 176: 5293-5298.
51. Kisielow M, Kisielow J, Capoferri-Sallami G, Karjalainen K (2005) Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells. Eur J Immunol 35: 2081-2088. (Pubitemid 41015047)
52. Workman CJ, Wang Y, El Kasmi KC, Pardoll DM, Vignali DAA, et al. (2009) LAG-3 regulates plasmacytoid dendritic cell homeostasis. J Immunol 182: 1885-1891.
53. Fallarino F, Asselin-Paturel C, Vacca C, Bianchi R, Puccetti P, et al. (2004) Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J Immunol 173: 3748-3754. (Pubitemid 39280736)
54. Martin P, Gloria M, Njuere F, Arias CF, Ardavin C, et al. (2002) Characterization of a new subpopulation of mouse CD8 alpha+B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 100: 383-390. (Pubitemid 34761097)
55. Bilsborough J, Geroge T, Norment A, Viney J (2003) Mucosal CD8 alpha + DCs, with plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties. Immunology 108: 481-492.